Day One Biopharmaceuticals (DAWN) Earnings Date & Reports
A.I. Advisor
published Earnings
DAWN is expected to report earnings to rise 1,386.60% to -74 cents per share on November 04
Q3'24
Est.
$-0.74
Q2'24
Beat
by $0.70
Q1'24
Missed
by $0.07
Q4'23
Missed
by $0.06
Q3'23
Beat
by $0.05
The last earnings report on July 30 showed earnings per share of -5 cents, beating the estimate of -75 cents. With 466.01K shares outstanding, the current market capitalization sits at 1.43B.